As of February 2025 Kiniksa Pharmaceuticals has a market cap of C$2.05 Billion. This makes Kiniksa Pharmaceuticals the world's 4908th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | C$2.05 B | -0.83% |
2024 | C$2.07 B | 26.7% |
2023 | C$1.63 B | 15.78% |
2022 | C$1.41 B | 36.78% |
2021 | C$1.03 B | -32.63% |
2020 | C$1.53 B | 93.27% |
2019 | C$0.79 B | -58.09% |
2018 | C$1.89 B |
On Feb 22nd, 2025 the market cap of Kiniksa Pharmaceuticals was reported to be: